Linking Emergency Department Patients to Assistance Programs Study
Launched by UNIVERSITY OF PENNSYLVANIA · Dec 8, 2022
Trial Information
Current as of February 05, 2025
Completed
Keywords
ClinConnect Summary
Every year, Philadelphians fail to claim approximately $450 million dollars in federal and state benefits1. Across the United States, unclaimed benefits are estimated at approximately $60 billion1. These benefits include support for food, housing, healthcare, economic support, and others that can make a significant impact on well-being, upward mobility, and financial stability. The reasons that benefits are unclaimed are numerous, including lack of awareness about benefit programs and eligibility criteria, lack of agency and self-efficacy in completing expansive application requirements and...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Patients will be included in the study based on the following criteria:
- • Adults at least 18 years of age
- • Patients must legally reside in Philadelphia
- • Patients receiving care from Penn Medicine Emergency Departments at the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Centerwho are deemed unlikely to require inpatient hospitalization or observation at the time of enrollment
- • Patients must have one of the following insurance plans: Medicaid and/or Medicare (managed and traditional).
- • Patient must be able to read/write in English.
- • Patients must be eligible for at least 1 of the benefits programs for which BDT can provide either direct application assistance or provide a referral to the social services agency website to submit applications.
- • Patients have a stable mobile phone number for the next 3 weeks.
- Exclusion Criteria:
- Patients will be excluded from participating in the study based on the following criteria:
- • Individuals \< 18 years
- • Patients deemed by ED physicians to be in critical or unstable condition
- • Does not speak/read English
- • Patient is in severe distress, e.g., respiratory, physical, or emotional distress
- • Patient is intoxicated, unconscious, or unable to appropriately respond to questions
- • Patients under police custody
- • Patients with a positive COVID-19 test
- • Patients with private health insurance benefits or without health insurance
- • Patients without a stable mobile phone number for the next 21 days
Trial Officials
Austin Kilaru, MD, MSHP
Principal Investigator
Principal Investigator
About University Of Pennsylvania
The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Philadelphia, Pennsylvania, United States
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials